e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025
05 févr. 2025 08h00 HE
|
e-therapeutics plc
LONDON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announced today that it will...
$15.7 Bn Haemophilia Treatment Market - Global Industry Trends Opportunities, and Forecasts, 2020-2030
13 janv. 2025 11h18 HE
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Haemophilia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
$115+ Billion Blood Plasma Derivatives Global Market Trends, Opportunities and Strategies to 2033: Innovative Formulations, Strategic Partnerships, and Increasing Investments to Drive Developments
28 nov. 2024 07h01 HE
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.Growth in the...
e-therapeutics Announces Business Updates and Interim Results
31 oct. 2024 09h00 HE
|
e-therapeutics plc
LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced business...
Hematology Collaboration and Licensing Deals Analysis Report and Directory 2024: Company A-Z, Headline Value, Therapeutic Area, Technology Type, Royalties
30 sept. 2024 05h14 HE
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The report provides access to deal...
Comprehensive Analysis of Hematology Collaboration and Licensing Deals (2016-2024) Unveiled
02 mai 2024 05h25 HE
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.A thorough report on hematology...
Global Hemophilia Market Report 2023: Increased Focus on Prophylactic Treatment Drives Growth
22 févr. 2023 04h28 HE
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2023-2027)" report has...
Plasma Derived Therapy Market worth USD 32 Billion by 2030, Says Global Market Insights Inc.
01 juin 2022 04h15 HE
|
Global Market Insights Inc.
Selbyville, Delaware , June 01, 2022 (GLOBE NEWSWIRE) -- The plasma derived therapy market value is projected to reach USD 32 billion by 2030, according to a new research report by Global Market...
Global Hemophilia Market Key Trends & Developments 2022-2026: Shifting Focus to Extended Half Life Therapies and Development of Novel Hemophilia Treatments
24 févr. 2022 06h48 HE
|
Research and Markets
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has...
Global Haemophilia Treatment Markets Analysis & Forecasts, 2016-2020 & 2021-2026
08 oct. 2021 07h33 HE
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Global Haemophilia Treatment Market, By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates,...